Comparison of inactivated, live and recombinant DNA vaccines against influenza virus in a mouse model
- 30 April 1990
- journal article
- research article
- Published by Elsevier BV in Virus Research
- Vol. 16 (1), 83-93
- https://doi.org/10.1016/0168-1702(90)90045-d
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Cross-protection against Microvariants of Influenza Virus Type B by Vaccinia Viruses Expressing Haemagglutinins from Egg- or MDCK Cell-derived Subpopulations of Influenza Virus Type B/England/222/82Journal of General Virology, 1989
- Protection against virulent H5 avian influenza virus infection in chickens by an inactivated vaccine produced with recombinant vaccinia virusVaccine, 1988
- Genetic Stability of A/Ann Arbor/6/60 Cold-Mutant (Temperature-Sensitive) Live Influenza Virus Genes: Analysis by Oligonucleotide Mapping of Recombinant Vaccine Strains Before and After Replication in VolunteersThe Journal of Infectious Diseases, 1984
- Immune responses in serum and respiratory secretions following vaccination with a live cold‐recombinant (cr35) and inactivated a/ussr/77 (h1n1) influenza virus vaccineJournal of Medical Virology, 1983
- Development of cold-adapted recombinant live, attenuated influenza A vaccines in the U.S.A. and U.S.S.R.Antiviral Research, 1982
- Cross‐protection and cross‐reactive cytotoxic T cells induced by influenza virus vaccines in miceEuropean Journal of Immunology, 1980
- Control of Influenza and Poliomyelitis with Killed Virus VaccinesScience, 1977
- Revised (1972-1973) bivalent influenza vaccine. Serum and nasal antibody responses to parenteral vaccinationJAMA, 1973
- Influenza Immunization: Field Trial on a University CampusThe Journal of Infectious Diseases, 1972
- Influenza Antibody in Human Respiratory Secretions after Subcutaneous or Respiratory Immunization with Inactivated VirusNature, 1968